$FNMA looks to have just found support at the bottom of a wedge after correcting from a long term downtrend. Should price get above $3.52, it looks like the next target could be $17.58. R/R is great from these levels with 17x+ upside for 20% of risk. Stop at $.69 and move up as price rises from here.
$ASPS over 1600 pre foreclosures alone in Las Vegas already, dont trust your realtor, possibly the worst time in history to buy a house, ride the foreclosure wave and invest in $ASPS. Nice consolidation and bear wedge, things baby is gonna be at the moon! Flush your mortgage stocks down the toilet $BAC $C $JPM $IMH $FBC $PFSI $PNC $WFC $FNMA $FMCC
Fannie Mae is setting up to be an interesting rectangular chart pattern. At some point FNMA will breakout and it'll be a high probability trade. Until then, the range lows offer an interesting long set-up with targets at the top of the range. This could take 2-5 years before breaking out (or less/more). From 1970 - 1986, FNMA did nothing except trade in a range...
Fannie Mae: The Road to Recapitalization Trade Ideas · Featuring Gaby Heffesse its just for me to track real vision trade idea . its only for journal purpose.
Both Fannie Mae ( FNMA ) and Freddie Mac ( FMCC ) are rocking and rolling. Mnuchin's interview paired with the court of appeals' move against the Gov't have sparked more interest here. This is great and another potential catalyst today could add fuel to the fire. HOWEVER, is there a motion likely before the election? I think the jury is still out on that front. ...
At this point FNMA might not be all speculation. "This latest plan is to return the two back to private hands. But as part of the plan, there would be a Treasury backstop in place. But this hasn’t come without pushback. Senate Banking Committee Senator Sherrod Brown has issues with this plan. The concern stems from possible risks that could arise by giving up...
FNMA price near to strong weekly support line. possibly buy. wait for 123 pattern for entry. I also watching this one .
All news aside it would be incredible to reach these levels again and fulfill decade long trend lines.
Target $4.00 from latest quote of $2.77. The size of the instrument is a great confidence booster, the market cap is less than $20,000,000,000.
It's been 10 Days since last bullish FNMA idea posted on this account and the stock outperformed. The target was $3-$5, the price cleared the bottom end of this target already.
FNMA (Fannie May) quote 2.36 at 3:28 PM 1/18/19 Massive volume and gains on Fannie May (FNMA) stock price today looking up towards $3-$6.
$USRM is currently awaiting RMAT designation which approved (And there is a 90% or higher chance it will) gives it similar qualities as Breakthrough Therapy, Accelerated Approval, and Priority Review. Basically, they can provisionally approve the drug or device for marketing and then provided the drug or device proves safe and reasonably effective, they will gain...
Let's recap $IDXG CC: 1. New York State and AETNA approvals of ThyraMIR®, microRNA assay 2. Talked about the Debt being restructured 3. No more offerings 4. Reduced operating costs 5. Talks of doing business with their BarreGen model 6. Talks of partnering with another bio he didn't discuss. 7. EPS value of $3.25 vs -($12.04) same quarter last year...
Technicals on $GEVO are far beyond bullish. We have the 50DMA curving under the current 30 min candle setup and the PARSAR has flipped bullish. An ascending cup is forming and it is poised for a breakout back to prior levels. In addition we also have the gap down from $2.50 to fill. LT after the ER is posted and wind of the technicals catches on we could see...
$NSAV Catalysts: 1. No R/S Announced 2. Reduction of A/S 3. Company merging with $CHIF to create a large MJ Recreational Spa and Resort at Naomi Villages in Colorado 4. Acquisition News on the horizon 5. Medical Cannabis Technology Business Announced Chart: Right now there was massive volume on Friday after no R/S was announced by the CEO in addition to the MJ...
$DTII Catalysts: 1. Ludlow Research predicts $1.00-$1.25 for this stock 2. R/S Cancelled 3. Demonstration of its patented Offender Alert Passive scan technology to the US Homeland Security Offices. 4. 3 Patents 2 Pending Chart: Very nice continuation after that massive run-up. Was hoping for more consolidation but we'll see if we get it, so far it's holding up on...
$ENDV Upcoming Catalysts: 1. Pre-Clinical Studies To Be Completed in first quarter of 2017 2. Application for IND Orphan Drug Status for its Cytotronics Product 3. Over 20 Patent Applications OWNED by the CEO and the Company 4. 10 Form 4s filed since Dec 2016 for Insider purchases of stock 5. A "Strategic Healthcare" Institutional Investor has Ponied up $15...
Three Key Factors happened today on $USRM 1. We had a Cloud break for the first time in a while 2. Volume Increased 3. Resistance became Support 4. Ultimate support held 5. Bullish trend continues